Patients Matter Video Series
The Patients Matter Video Series is a series of short videos developed by FDA’s Office of Patient Affairs to teach patients and other stakeholders about FDA and patient engagement efforts. The video series is intended to educate patients and other stakeholders about FDA, encourage them to share their perspectives on living with a disease or condition, and provide information about how to contact the Agency.
- Patients Matter
- Giving Patients A Seat at the Table
- FDA's Office of Orphan Products Development
- How Rare Disease Patients Can Move Scientific Discovery Forward
- What is Expanded Access?
- What is an FDA Patient Listening Session?
- FDA Patient Listening Sessions: Community Perspectives
- FDA Patient Listening Sessions: FDA Staff Reflections (NEW)
Learn about how FDA wants to hear from and engage with patients, caregivers, and patient advocates in this introduction to the Patients Matter video series
Watch video.
Patients Matter: Giving Patients A Seat at the Table
Learn about five different kinds of meetings, forums, and committees at which patients, caregivers, and advocates are invited to sit at the table with FDA and share their ideas, experiences, and concerns.
Watch video.
Patients Matter: FDA's Office of Orphan Products Development Grants Program
Learn about how FDA is administering funding to support innovative clinical trial methods and research for the millions of people with rare diseases through the Orphan Products and Natural History Grants Programs. These grants are open to foreign or domestic, public or private, for-profit or nonprofit entities, including patient advocacy groups, academicians, and industry.
Watch video.
Patients Matter: How Rare Disease Patients Can Move Scientific Discovery Forward
Learn about how patients, caregivers, and advocates can get involved in natural history studies and clinical trials to help scientists develop treatments for patients with rare diseases.
Watch video.
Patients Matter: What is Expanded Access?
Learn about FDA’s Expanded Access Program, when Expanded Access could be an option, the process for requesting Expanded Access and hear a family’s experience with the Program.
Watch video.
Resources for Patients:
FDA’s Expanded Access patient webpage
Connect with FDA regarding the Expanded Access Program
Resources for Health Providers:
FDA’s Expanded Access physician webpage
Assistance with an oncology Expanded Access request
Patients Matter: What is an FDA Patient Listening Session?
Learn about why you should request a session and what happens during an FDA Patient Listening Session. FDA Patient Listening Sessions give patients, caregivers and patient organizations an opportunity to connect directly with the FDA about their health condition and help us understand what is most important including the physical and emotional burdens.
Watch video.
FDA Patient Listening Sessions: Community Perspectives
Patients, caregivers and advocates describe their experiences with the FDA Patient Listening Session program.
FDA Patient Listening Sessions: Community Perspectives
Patients, caregivers and advocates describe their experiences with the FDA Patient Listening Session program.
Watch video.
FDA Patient Listening Sessions: Community Perspectives
Patients, caregivers and advocates explore ways the FDA Patient Listening Session program has benefited their communities.
Watch video.
FDA Patient Listening Sessions: Community Perspectives
Patients, caregivers and advocates discuss why other patient communities should get involved with the FDA Patient Listening Session program.
Watch video.
FDA Patient Listening Sessions: Community Perspectives
Patients, caregivers and advocates discuss why communities should consider requesting an FDA Patient Listening Session.
Watch video.
FDA Patient Listening Sessions: National Organization for Rare Disorders (NORD)
Debbie Drell, Director of Membership at the National Organization for Rare Disorders (NORD) describes the importance FDA Patient Listening Sessions and NORD’s role in the program.
FDA Patient Listening Sessions: The Reagan-Udall Foundation for the FDA
Alec Halsne of the Reagan-Udall Foundation for the FDA describes the importance FDA Patient Listening Sessions and the Reagan-Udall Foundation for the FDA’s role in the program.
FDA Patient Listening Sessions: FDA Staff Reflections
FDA Staff reflect and provide their insights from the FDA Patient Listening Session program.
FDA Patient Listening Sessions: FDA Staff Reflections – Melanie Blank
Melanie Blank from FDA’s Center for Biologics Evaluation and Research (CBER) outlines how FDA Patient Listening Sessions can benefit patient communities.
FDA Patient Listening Sessions: FDA Staff Reflections – Lewis Fermaglich
Lewis Fermaglich from FDA’s Office of Orphan Products Development describes an impact of the FDA Patient Listening Session program.
FDA Patient Listening Sessions: FDA Staff Reflections – Erica Lyons
Erica Lyons from FDA’s the Center for Drug Evaluation and Research (CDER) shares an example of how the information she heard during an FDA Patient Listening Session informed her work.
FDA Patient Listening Sessions: FDA Staff Reflections – Anne Rowzee
Anne Rowzee from FDA’s Center for Biologics Evaluation and Research (CBER) shares how the FDA Patient Listening Session program provides insight into the work she does at FDA.
FDA Patient Listening Sessions: FDA Staff Reflections – Julienne Vaillancourt
Julienne Vaillancourt from FDA’s Center for Biologics Evaluation and Research (CBER) explains how FDA Patient Listening Sessions have informed her work at FDA.
When a Patient Speaks: Testimonials from FDA Patient Representatives
FDA Patient Representatives continue to make important contributions to the agency as medical products are regulated. It’s through the FDA Patient Representative Program® that both patients and caregivers are able to demonstrate their strengths as advocates and ambassadors to their communities. "When a Patient Speaks" is a series of short videos where experienced FDA Patient Representatives share what it means to serve in their unique role, the impact that it’s had on their lives, the lessons learned as they’ve served, and more.
For more information about how you can engage with FDA, contact FDA’s Office of Patient Affairs at PatientAffairs@fda.gov.